2-236167550-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000306318.5(GBX2):c.422C>T(p.Ala141Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000375 in 1,598,958 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000306318.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GBX2 | NM_001485.4 | c.422C>T | p.Ala141Val | missense_variant | 1/2 | ENST00000306318.5 | NP_001476.2 | |
GBX2 | NM_001301687.2 | c.422C>T | p.Ala141Val | missense_variant | 1/3 | NP_001288616.1 | ||
GBX2 | XM_047443907.1 | c.422C>T | p.Ala141Val | missense_variant | 1/4 | XP_047299863.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GBX2 | ENST00000306318.5 | c.422C>T | p.Ala141Val | missense_variant | 1/2 | 1 | NM_001485.4 | ENSP00000302251 | P1 | |
GBX2-AS1 | ENST00000415226.1 | n.104G>A | non_coding_transcript_exon_variant | 1/4 | 4 |
Frequencies
GnomAD3 genomes AF: 0.000224 AC: 34AN: 152072Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000451 AC: 10AN: 221518Hom.: 0 AF XY: 0.0000245 AC XY: 3AN XY: 122698
GnomAD4 exome AF: 0.0000173 AC: 25AN: 1446778Hom.: 0 Cov.: 34 AF XY: 0.0000153 AC XY: 11AN XY: 719532
GnomAD4 genome AF: 0.000230 AC: 35AN: 152180Hom.: 0 Cov.: 32 AF XY: 0.000242 AC XY: 18AN XY: 74396
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 20, 2023 | The c.422C>T (p.A141V) alteration is located in exon 1 (coding exon 1) of the GBX2 gene. This alteration results from a C to T substitution at nucleotide position 422, causing the alanine (A) at amino acid position 141 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at